Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company

Edinburgh Molecular Imaging Limited

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 27th September 2026 · Sources

Network

The large node is Edinburgh Molecular Imaging Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 11

  1. Dr Robert Ian James 2023-2025 Director View profile
  2. Dr Daniel John Marshall 2021-2021 Director View profile
  3. Dr Bernhard Michael Sixt 2018-2022 Director View profile
  4. Gordon Roy Davis 2018-2023 Director View profile
  5. David John Jeans 2015-2025 Director View profile
  6. Andrew Sinclair Dunlop 2014-2021 Director View profile
  7. Professor Kanwaldeep Dhaliwal 2014-2018 Director View profile
  8. Professor Mark Bradley 2014-2018 Director View profile
  9. Professor Christopher Haslett 2014-2018 Director View profile
  10. Barry Kenneth Knight 2015-2022 Secretary View profile
  11. Simon Jones 2014-2015 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

Incorporated
13/01/2014

Ownership

Owned by (1) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

Group

  1. Edinburgh Molecular Imaging Limited is controlled by Epidarex Capital II, LP
    Evidence
    active 25-50% shares, 25-50% voting · notified 2016-04-06 · source: Companies House PSC register
  2. Epidarex Capital II, LP is controlled by ELI Lilly and Company Limited
    Evidence
    active part right to share surplus assets 25 to 50 percent · notified 2017-06-26 · source: Companies House PSC register
  3. ELI Lilly and Company Limited is controlled by ELI Lilly Group Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors (firm), significant influence (firm) · notified 2016-04-06 · source: Companies House PSC register

Ultimately controlled by ELI Lilly Group Limited.

23 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

2 directors on the board

7.6y median 7.6y
average tenure
12.5y
longest tenure

Directors past 6 years

First-time vs portfolio directors

First-time (1)

Portfolio (1)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Professional services 5Finance 2

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
SC467269
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 27th September 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data